Key result
Sutureless aortic valve replacement is associated with postoperative permanent pacemaker implantation rates ranging from 6.8% to 23%, emphasizing the need to optimize implantation techniques.
Why the study?
Does sutureless aortic valve replacement increase the risk of permanent pacemaker implantation compared to TAVI or stented valves in patients with aortic stenosis?
Does sutureless aortic valve replacement increase the risk of permanent pacemaker implantation compared to TAVI or stented valves in patients with aortic stenosis?
Answers are grounded in this paper and cite their sources.
While sutureless aortic valve replacement facilitates minimally invasive surgery, continuous evaluation and refinement of implantation techniques are crucial to reduce the associated high risk of postoperative permanent pacemaker implantation.
In the era of transcatheter aortic valve implantation (TAVI) programme, cardiac surgeons are bound to adapt their surgical strategies to prove that conventional aortic valve replacement (AVR) is indisputably here to stay. Minimally invasive approach to promote early recovery and shorter hospital stay is one of the surgical modifications that has gained popularity. Meanwhile, TAVI has become a feasible alternative even in moderate-risk patients. Moreover, studies involving TAVI in low-risk patients are currently conducted. Nevertheless, the emergence of sutureless valve prostheses has facilitated minimally invasive surgery and comprises a promising technology. Sutureless aortic valve replacement (SU-AVR) has become a widely used treatment modality due to its satisfying haemodynamic performance and reduction of aortic cross-clamp and cardiopulmonary bypass time [1]. On the other hand, the use of sutureless aortic valves is associated with higher postoperative permanent pacemaker implantation (PPI) in comparison to stented bioprostheses, which remains a considerable concern. Similar to those of TAVI, several studies on sutureless valves reported high PPI rates ranging between 6.8% and 23% [2, 3]. It has been reported that postoperative conduction disorders and those leading to PPI after TAVI are associated with increased morbidity and mortality [4]. Therefore, in terms of decision-making with regard to TAVI or surgical approach (either with sutureless or stented valves) in patients with aortic stenosis, PPI rates should be taken into account. Apart from the less-invasive approach, TAVI has also proven its excellent haemodynamic performance and lower gradients, even in smaller annuli compared to stented valves. However, to date, one of the key advantages of stented aortic valve is its significant lower PPI rates. Subsequently, the added clinical value of sutureless valves above TAVI diminishes, when all of the above is similar along with the incidence of conduction disturbances and need of postoperative PPI. We might also look at this from another perspective; if sutureless valve prostheses have similar advantages as TAVI compared to stented valves, sutureless valve might potentially become even more valuable when lower PPI rates are achieved. This emphasizes that it is of great importance to identify possible risk factors for PPI in sutureless valves and if possible, to tackle this issue. In a well-conducted retrospective study, Vilalta et al. [5] evaluated the incidence, prognostic value and possible predictors of PPI in low-risk aortic stenosis patients after sutureless valve implantation. Data concerning long-term durability (>10 years) of the sutureless bioprosthesis are still lacking in the literature. Although the available published data of mid-term performance are promising, the choice for the sutureless bioprosthesis in relatively young patients remains a concern. This means that age is possibly more important than the EuroSCORE in patient selection. As we earlier stated [6, 7], EuroSCORE does not accurately estimates the risk of early mortality in patients undergoing AVR. In the current study of Vilalta et al. [5], the mean age of the whole population was 77.2 ± 6.2 years, which is relatively old concerning the AVR population. In concordance to earlier studies, the authors reported an incidence of 9% PPI after SU-AVR. Also, an increased risk of PPI was observed in patients with prior right bundle branch block. As stated by the authors, a better knowledge of factors determining the higher occurrence of conduction disorders in patients undergoing SU-AVR is of great clinical relevance. In addition to patient selection, attempts to modify implantation techniques to improve PPI rates have been described. It has been speculated that decalcification strategy and higher placement of the guiding sutures could be a contributing factor in reducing conduction abnormalities. In concordance with TAVI, radial forces during deployment of the Perceval sutureless valve® (Corcym S.r.l., Saluggia, Italy) have been proposed to result in compression of the conduction system. Concerning this matter, Vogt et al. [8] demonstrated that adjusting some aspects of the implantation technique, such as appropriate decalcification, adequate positioning of the guiding sutures and releasing of commissural traction sutures, resulted in a PPI rate of 8.1%. Notably, the authors claim that reduced pressure of balloon insufflation is a key element in reduction of postoperative PPI. Despite this modified implantation technique, the incidence of PPI remains considerably high in comparison with the stented bioprostheses. It has been suggested that other risk factors or technical implantation aspects such as oversizing could play a putative role in postoperative PPI. As for the Perceval sutureless valve prosthesis, several reports were published on the role of oversizing and the incidence of paravalvular leakage and increased postoperative transvalvular gradient [9]. Moreover, in a recent study, Szecel et al. [10] compared 2 sizing techniques of the Perceval valve (before and after oversizing) and found a significantly decreased postoperative PPI rate from 11% to 6.1%. These initial findings are promising, but further literature on avoidance of oversizing is still scarce and stented bioprostheses still have superior excellent results on postoperative pacemaker requirements. Parallel to this, alterations in implantation strategy and valve design of transcatheter valves throughout the years have led to similar significant decline of postoperative PPI percentages. To further reduce the need of postoperative PPI, the manufacturer has modified the Perceval valve® by shortening the height of the sealing collar (Perceval Plus model). In this light, it might be well worth to explore the effect of this altered design on pacemaker requirements parallel to gaining more data on the possible consequence of avoiding oversizing on postoperative PPI incidence. Ultimately, the main lesson we can draw from the study of Vilalta et al. [5] is that continuous evaluation and evolving implantation techniques if possible is of great importance to maintain future perspectives in sutureless valves.
No takes yet. Share an insight, caveat, or question.
Ka Yan Lam (2022) conducted an editorial in Aortic stenosis. Sutureless aortic valve replacement (SU-AVR) vs. Stented bioprostheses and TAVI was evaluated on Postoperative permanent pacemaker implantation (PPI). Sutureless aortic valve replacement is associated with postoperative permanent pacemaker implantation rates ranging from 6.8% to 23%, emphasizing the need to optimize implantation techniques.
Synapse has enriched 10 related papers. Consider them for comparative context: